Avid Bioservices Inc (CDMO)

[biopharm]

Harold Dvorak : Peregrine Pharmaceuticals KOL : Cancer starts with Inflammation : Part III : very interesting video and throughout the video (15 views as of this post)

... just ask yourself over and over, what decreases MDSC's, what decreases chronic inflammation? Bavituximab/PS Targeting agents!

.... yes, chronic inflammation will be proven to hold higher MDSC's and here is the video that was posted of Dr. Harold Fisher Dvorak from the previous post and its all based on the findings that chronic inflammation basically leads to cancer. So if higher MDSC's are bad and higher MDSC's hold that chronic inflammation...

well like we have been saying for months, decreased MDSC's is good! and what causes decreased MDSC's ? Yes... PS Targeting and Bavituximab is just one of the most probable large line of the anti-PS targeting agents, all which Peregrine Pharmaceuticals holds those PS Targeting IP rights 100%.

Very good video and many do not realize how well known, globally... Dr. Harold Fisher Dvorak is and respected and he was one of the very early Peregrine Scientific Advisors/KOL's